Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5267204
Max Phase: Preclinical
Molecular Formula: C39H36O18
Molecular Weight: 792.70
Associated Items:
ID: ALA5267204
Max Phase: Preclinical
Molecular Formula: C39H36O18
Molecular Weight: 792.70
Associated Items:
Canonical SMILES: C=CCOc1c(OC(C)=O)cc(C(=O)O[C@@H]2Cc3c(OC(C)=O)cc(OC(C)=O)cc3O[C@@H]2c2cc(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c2)cc1OC(C)=O
Standard InChI: InChI=1S/C39H36O18/c1-9-10-48-37-31(51-20(4)42)13-26(14-32(37)52-21(5)43)39(47)57-35-17-28-29(50-19(3)41)15-27(49-18(2)40)16-30(28)56-36(35)25-11-33(53-22(6)44)38(55-24(8)46)34(12-25)54-23(7)45/h9,11-16,35-36H,1,10,17H2,2-8H3/t35-,36-/m1/s1
Standard InChI Key: JSDOSVKLCFUPTK-LQFQNGICSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 792.70 | Molecular Weight (Monoisotopic): 792.1902 | AlogP: 4.63 | #Rotatable Bonds: 13 |
Polar Surface Area: 228.86 | Molecular Species: NEUTRAL | HBA: 18 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.33 | CX LogD: 3.33 |
Aromatic Rings: 3 | Heavy Atoms: 57 | QED Weighted: 0.13 | Np Likeness Score: 0.78 |
1. Lee H, Jeong JH, Lee T, Chong Y, Choo H, Lee S.. (2023) Identification of (-)-Epigallocateshin gallate derivatives promoting innate immune activation via 2',3'-cyclic GMP-AMP-stimulator of interferon genes pathway., 90 [PMID:37182610] [10.1016/j.bmcl.2023.129325] |
Source(1):